Biogen (BIIB) EV to CFO (2009 - 2026)
Biogen (BIIB) posted EV to CFO of 68.25 for Q2 2026, up 93.37% on a QoQ basis from 35.3 in Q1 2026, and down 29.85% year-over-year from 97.29 in Q2 2025.
Analysis
Biogen (BIIB) EV to CFO (2009 - 2026) Analysis & Trends
Biogen has reported EV to CFO for 18 years, with the latest figure at 68.25 in Q2 2026.
- On a quarterly basis, EV to CFO fell 29.85% year-over-year to 68.25 in Q2 2026; TTM through Jun 2026 was 10.64, a 43.91% increase from a year earlier, with the FY2025 full-year figure at 9.99, up 44.17% from the prior year.
- EV to CFO was 68.25 for Q2 2026 at Biogen, up from 35.3 in the prior quarter.
- The five-year high for EV to CFO was 2915.67 in Q4 2023, with the low at 199.85 in Q4 2022.
- Average EV to CFO over 5 years is 203.36, with a median of 52.86 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: EV to CFO plunged 631.37% in 2022, then surged 1558.91% in 2023.
- Over 5 years, EV to CFO stood at 199.85 in 2022, then soared by 1558.91% to 2915.67 in 2023, then sank by 99.1% to 26.18 in 2024, then jumped by 64.3% to 43.02 in 2025, then jumped by 58.67% to 68.25 in 2026.
- The last three EV to CFO figures came in at 68.25 (Q2 2026), 35.3 (Q1 2026), and 43.02 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.25 |
| Mar 31, 2026 | 35.30 |
| Dec 31, 2025 | 43.02 |
| Sep 30, 2025 | 13.04 |
| Jun 30, 2025 | 97.29 |
| Mar 31, 2025 | 67.31 |
| Dec 31, 2024 | 26.18 |
| Sep 30, 2024 | 28.37 |
| Jun 30, 2024 | 50.91 |
| Mar 31, 2024 | 54.81 |
| Dec 31, 2023 | 2,915.67 |
| Sep 30, 2023 | 58.99 |
| Jun 30, 2023 | 72.21 |
| Mar 31, 2023 | 77.29 |
| Dec 31, 2022 | -199.85 |
| Sep 30, 2022 | 50.72 |
| Jun 30, 2022 | 33.66 |
| Mar 31, 2022 | 167.30 |
| Dec 31, 2021 | 37.61 |
| Sep 30, 2021 | 48.51 |